BIOGEN INC's ticker is and the CUSIP is 09062X953. A total of 9 filers reported holding BIOGEN INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,032,718 | -41.2% | 11,800 | -34.8% | 0.00% | -40.0% |
Q2 2023 | $5,155,785 | -66.9% | 18,100 | -67.7% | 0.01% | -72.2% |
Q1 2023 | $15,597,483 | -36.1% | 56,100 | -36.4% | 0.02% | -52.6% |
Q4 2022 | $24,424,344 | -77.3% | 88,200 | -78.1% | 0.04% | -72.7% |
Q3 2022 | $107,708,000 | +1160.5% | 403,400 | +862.8% | 0.14% | +1058.3% |
Q2 2022 | $8,545,000 | +130.5% | 41,900 | +138.1% | 0.01% | +200.0% |
Q1 2022 | $3,707,000 | -87.8% | 17,600 | -86.1% | 0.00% | -84.0% |
Q4 2021 | $30,470,000 | -63.6% | 127,000 | -47.5% | 0.02% | -75.7% |
Q2 2021 | $83,728,000 | +466.8% | 241,800 | +358.0% | 0.10% | +390.5% |
Q1 2021 | $14,771,000 | -57.5% | 52,800 | -62.8% | 0.02% | -52.3% |
Q4 2020 | $34,770,000 | +62.8% | 142,000 | +88.6% | 0.04% | +29.4% |
Q3 2020 | $21,361,000 | +33.1% | 75,300 | +25.5% | 0.03% | +3.0% |
Q2 2020 | $16,053,000 | +46.2% | 60,000 | +72.9% | 0.03% | +43.5% |
Q1 2020 | $10,978,000 | -50.4% | 34,700 | -53.5% | 0.02% | -59.6% |
Q4 2019 | $22,136,000 | +116.1% | 74,600 | +69.5% | 0.06% | +78.1% |
Q3 2019 | $10,244,000 | -9.5% | 44,000 | -9.1% | 0.03% | -13.5% |
Q2 2019 | $11,319,000 | -9.3% | 48,400 | -8.3% | 0.04% | -17.8% |
Q1 2019 | $12,481,000 | +29.2% | 52,800 | +64.5% | 0.04% | +50.0% |
Q4 2018 | $9,660,000 | – | 32,100 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 2,451 | $62,891,000 | 9.72% |
SIMPLEX TRADING, LLC | 1,053 | $30,561,000 | 0.12% |
GROUP ONE TRADING, L.P. | 45,800 | $13,293,000 | 0.11% |
Allianz Asset Management GmbH | 162,900 | $47,280,000 | 0.05% |
SG Americas Securities, LLC | 163,700 | $3,627,000 | 0.03% |
JPMORGAN CHASE & CO | 221,750 | $64,361,000 | 0.01% |